Dr.csn institute of pharmacy Bhimavaram, Andhra Pradesh-534203
Researchers from Chalmers Insitute of Technology (CTH) and the University of Freiburg have proposed an interesting technique that enables chronic wounds to heal faster than ever. Medical conditions like diabetes, cancer, disturbed blood circulation, and spinal injuries can sometimes impair our body’s natural ability to heal wounds. Patients who live with such conditions often experience wounds that don’t heal.These unrepaired chronic wounds become a source of infection and sometimes even lead to amputations, making patients’ lives very difficult. In their latest study, the researchers claim to heal chronic wounds three times faster using electric current showing majority of improvement.
Electricity has been used in so many applications in the past, but its use to heal wounds is an emerging field that is gaining people's interest in research and the health arena. Recently, a study made some discoveries that could validate that electricity can heal wounds to a more impressive extent by threefold on even the worst cases. This groundbreaking discovery not only illuminates the complex mechanisms of electrical healing but will eventually become the innovation in the field for new approaches in medical treatment and wound care. We explore here the transformative power of electricity in wound healing through our look into the key findings of the study, its implications for healthcare practices and the future prospects of integrating electrical stimulation in clinical settings.
How electricity actually heal wounds
Our skin is our body’s largest external organ and it plays a crucial role in acting as the first line of defense against mechanical and pathogenic threats, and ideally, any injury to this barrier will be repaired rapidly [1]. A wound is any injury causing a break in the structure of living tissue, which may go beyond the skin’s epithelial layer to affect the underlying subcutaneous structures depending on the extent of damage [1]. Wound healing is a complex yet well-orchestrated physiological process involving a variety of cells and chemical mediators. The series of events involved in wound healing can be broadly classified into three main phases: (a) The inflammatory phase, (b) the proliferative phase, and (c) the remodeling phase [1]. The events occurring in these phases involve hemostasis to control bleeding, migration of inflammatory cells to the wound site (chemotaxis), granulation tissue formation, collagen repair, vascularization, and re-epithelialization [2]. These important events work through a signaling system coordinated by a myriad of mediators such as growth factors and cytokines [2]. Examples of these include transforming growth factor (TGF), insulin-like growth factor (IGF), fibroblast growth factor (FGF), vascular endothelial growth factor (VEGF), keratinocyte growth factor (KGF), and platelet derived growth factor (PDGF), that collectively help induce differentiation of immune cells to clear debris and fight infection, stimulate growth, promote formation of new blood vessels, and release inflammatory mediators [3]. Figure 1 depicts the stages of cutaneous wound healing (specifically Figure 1A depicts a wound during the inflammatory phase of healing and Figure 1B depicts a wound during the proliferative and remodeling phase of healing) and the respective growth factors released to stimulate immune cells and cutaneous structures.

Figure 1. (A) A cutaneous wound 3 days after injury. Growth factors thought to be necessary for cell movement into the wound are shown. TGF-?1, TGF-?2, and TGF-?3 denote transforming growth factor ?1, ?2, and ?3, respectively; TGF-? transforming growth factor ?; FGF fibroblast growth factor; VEGF vascular endothelial growth factor; PDGF, PDGF AB, and PDGF BB platelet-derived growth factor, platelet-derived growth factor AB, and platelet-derived growth factor BB, respectively; IGF insulin-like growth factor; and KGF keratinocyte growth factor. (B) A cutaneous wound 5 days after injury. Blood vessels are seen sprouting into the fibrin clot as epidermal cells resurface the wound. Proteinases thought to be necessary for cell movement are shown. The abbreviation u-PA denotes urokinase-type plasminogen activator; MMP-1, 2, 3, and 13 matrix metalloproteinases 1, 2, 3, and 13 (collagenase 1, gelatinase A, stromelysin 1, and collagenase 3, respectively); and t-PA tissue plasminogen activator. Images reproduced with permission from [4]. The wound healing process is also influenced by our skin’s endogenous electric potential [5], also dubbed the endogenous “skin battery” [6]. In undamaged skin, a natural electrical potential of 10–60 mV between the epidermal and sub-epidermal layer exists [6]. This is largely attributed to the transport of ions through ion channels and the frequent depolarization and repolarization of cells [7]. This trans-epithelial voltage (TEP) largely increases around a wound. The disruption to the epithelium by an injury creates a short-circuit to the TEP, driving positive electrical flow towards the wound, as depicted in Figure 2. [8,9].

Injuries produce an electric current [10], and clinical studies have shown that the voltage difference between the wound site and the undamaged skin ranges between 100 and 150 mV/mm [7,8,9].
Figure 2. The current of injury is thought to be significant in initiating repair. Undamaged human skin has an endogenous electrical potential and a transcutaneous current potential of 20–50 mV. This is generated by the movement of sodium ions through Na+/K+ ATPase pumps in the epidermis. The current of injury is generated through epithelial disruption. Following an injury to the skin, a flow of current through the wound pathway generates a lateral electrical field and this is termed the “current of injury” or “skin battery” effect. Image reproduced with permission from [11]. These endogenous electric fields play a critical role in wound healing [7,8], with resulting endogenous currents acting as a cue for cellular migration which concomitantly help heal wounds [8]. In addition, it is noteworthy that without this current, it is estimated that the average healing rate decreases by 25% [12]. This phenomenon motivates the exploration of the use of electrical stimulation (ES) to accelerate wound healing for various applications [13]. Most cutaneous lesions take a week or two to heal. However, this is prolonged in chronic wounds, which do not progress systematically through the healing stages [14]. This can be due to factors that hamper the wound healing process such as age, obesity, smoking, nutritional deficiencies or underlying diseases that predispose patients to develop chronic wounds (e.g., diabetes mellitus and/or peripheral venous disease) [14]. In conditions such as diabetes, wounds remain in a chronic inflammatory phase due to impaired cellular migration, growth factor release, and poor microcirculation [15]. In addition to this, chronic wounds host various microbes that colonize and multiply within the unhealed tissue, further contributing to impaired healing [15]. Chronic wounds broadly include diabetic ulcers, pressure sores, and ulcers caused by arterial and venous insufficiency (vascular ulcers) [16]. Figure 3 depicts these chronic wounds and their pathophysiology is briefly described in Table 1 [17]. The staging of pressure and diabetic foot ulcers is outlined in Appendix A. Some researchers postulate that the endogenous current observed upon injury is markedly reduced in chronic wounds, contributing to its impaired healing [18]. Although these wounds have different etiologies, they possess common characteristics including: Excessive inflammation, tendency to get recurrent infection, improper vascularization, and slower migration of epithelial cells to mediate repair [17,18,19].

Figure 3. Types of chronic wounds (from left to right): Venous leg ulcer, arterial leg ulcer, neuropathic diabetic foot ulcer, and pressure ulcer. Image adapted with permission from [20].
Types of electrical stimulation
Electrical stimulation is used for a variety of clinical applications, such as fracture repair, pain management, and wound healing. Several different applications of electricity have been described, including direct current (DC), alternating current (AC), high-voltage pulsed current (HVPC), and low-intensity direct current (LIDC). Physicians are probably most familiar with pulsed electromagnetic field (PEMF) for repair of fracture non-unions and transcutaneous electrical nerve stimulation (TENS) for pain control (29, 30). Frequency rhythmic electrical modulation systems (FREMS) is a form of transcutaneous electrotherapy using electrical stimulation that automatically varies in terms of pulse, frequency, duration, and voltage (31). Even through the electrical stimulation and wound healing literature uses several different types of electrical stimulation, they all seem to have positive results.
Treatment Side Effects
the concept of using electricity on the body may sound painful and horrifying, it is not so in actuality. Many people find the sensation relaxing. People experience a tingling, vibrating, or buzzing sensation which is not unpleasant. It includes a range of treatments using electricity to reduce pain, improve circulation, repair tissues, strengthen muscles and promote bone growth. However, the most common side effect with electrotherapy is skin irritation, which is even caused by the overuse of adhesives electrodes or the tape holding the electrodes in place.
Although there are no side effects of Electrotherapy devices, there are few recommendation applies to the following people:
Pregnant women. People with epilepsy. People with heart problems or any type of electrical or metal implant. Not to be applied over organs or infectious area of the skin.
Study limitations
There are several limitations to this review. There were several different applications of electrical stimulation (PEMF, TENS, high voltage galvanic stimulation), different doses, and durations of therapy that were studied and reported. In addition, many of the studies were small and may have been underpowered. And unlike industry-sponsored phase-three clinical trials, many studies looked at percent change in wound area at 4–6 weeks as the primary outcome rather than complete wound healing at 12 or 20 weeks. Despite variations in the type of current, duration, and dosing of electrical stimulation, the majority of trials showed a significant improvement in wound area reduction or wound healing compared to the standard of care or sham therapy (Table 2) as well as improved local perfusion (Table 1). In fact, these factors were different in all 16 RCTs
|
Author |
Pathology of interest |
Duration of treatment |
Treatment specification: voltage, current, phase duration, frequency |
Population |
Outcome |
|
Gilcreast (Citation45) |
Perfusion in DFU and high-risk population using HPVC |
Once |
100 V, 100 pps, 0.07 pulse duration |
Treatment n=132 |
TcpO2 significant improvement in 27% of subjects (p<0>
Laser Doppler flow NS. |
|
Clover (Citation35) |
Perfusion in stable claudication using TENS |
1 hour, TID, for 6 weeks |
1.0 V, 10 mA, 8 Hz |
Treatment n=24, Control: n=12 |
Capillary density increased treatment 25% vs. control 0% p<0>p>0.05, raw value NS. |
|
Cramp (Citation36) |
Perfusion in health humans using TENS |
Once, 15 min |
High frequency = 110 Hz, 200 µs |
High frequency n=10 |
TcpO2 NS. |
|
Forst (Citation46) |
Perfusion in neuropathic patients using TENS |
Once, 3 min |
0.2 ms at 4 cycles/s 70 mA or painless muscle contraction |
NP-/RP? n=14, NP + /RP? n=14, NP ? /RP+ n=8, NP + /RP + n=21, |
TcpO2 NS. |
|
Peters (Citation44) |
Perfusion in diabetics using DC |
60 min, QID, for 1 day |
50 V, 100 twin-peak monophasic pps |
Diabetics with PAD n= 11 |
TcpO2 significant improvement in patients with PAD 27% (p<0>
Laser Doppler blood flow no difference (p=0.27) |
|
Griffin (Citation41) |
Venous flow with TENS |
Twelve increments in stimuli per minute (spm) |
0–5 V, 50 ms, 2–120 spm |
Healthy volunteers n = 24 |
Peak systolic velocity in popliteal artery was 10 times higher at 2–8 spm than baseline |
*Single-blind RCT; **double-blind RCT; NS, not stated; pps: pulse per second.
|
Author |
Pathology of interest |
Duration of treatment |
Treatment specification; |
Population |
Outcome |
|
Peters (Citation54) |
DFU using DC |
8 hours, nightly, for 12 weeks |
50 V, 80 twin-peak monophasic pps for 10 min, 8 pps for 10 min, then 40 min standby cycles |
Treatment n=20. |
Wound healing ES 65% vs. sham 35% p=0.058. |
|
Adunsky (Citation56) |
Pressure ulcers using DC |
20 min, TID, 7 day a week, for 2 weeks. Then BID for 6 weeks |
NS |
Treatment n=19 Sham** n=19 |
Wound healing ES 26% vs. sham 16% p=0.39. |
|
Griffin (Citation57) |
Pressure ulcers ion males using HVPC |
60 min, daily, for 20 consecutive days |
200 V, total current 500 µA, 100 pps |
Treatment n=8 |
Wound healing ES 38% s 22% p>0.05. |
|
Houghton (Citation58) |
Pressure ulcers using HVPC |
60 min, TID, for 3 months. |
50–150 V. 50 µs pulses. |
Treatment n=16, Sham* n=18 |
Wound healing ES 38% vs. control 28% p>0.05. |
|
Salzberg (Citation59) |
Pressure ulcers in males using PEMF |
30 min, BID, 7 days a week, for 12 weeks |
Radio frequency of 27.12 MHz, 80–600 pps, a duty cycle between 0.5–3.9% and 293–975 W |
Treatment n=9. |
Wound healing ES 100%, average 14 days vs. sham 100%, average 35 days p=0.007. |
|
Wood (Citation60) |
Pressure ulcer using DC. |
Three time a week, for 8 weeks. |
600 µA, 0.8 Hz. |
Treatment n=41 |
Wound healing ES 58% vs. sham 3% p<0>
Wound area reduction NS. |
|
Ieran (Citation61) |
Venous ulcers using PEMF |
3–4 hours, daily, 7 days a week, for 90 days. |
2.8 mT, 75 Hz, 1.3-ms pulse width |
Treatment n = 18 |
Wound healing ES 67% vs. sham 32% p<0>
Wound area reduction ES 47% vs. sham 30%, p>0.05. |
|
Lundeberg (Citation62) |
Venous ulcers using AC |
20 min, BID, for 12 weeks. |
80 Hz, 1-ms pulse width. Polarity was reversed after each treatment |
Treatment n=24 |
Wound healing ES 41% vs. sham 15% p<0> Wound area reduction ES 59% vs. sham 39% p<0> Adverse event: 6% ES and 3% sham had allergy, 9% ES and 6% sham had pain, 9% ES and 6% sham non-compliant. |
|
Stiller (Citation20) |
Venous ulcers using PEMF |
3 hours, daily, 7 days a week, for 8 weeks. |
0.06 mV/cm. The signal is 3-part pulse (+, ?, +) of 3.5-ms width |
Treatment n=18, Sham** n=13 |
Wound healing NS. |
|
Santamato (Citation9) |
Venous leg ulcer healing using FREMS |
25 min, 5 days a week, 3 weeks |
Maximum impulse amplitude preset to the value according to patient's sensitivity threshold |
Treatment n=10 |
Wound healing NS. |
|
Carley (Citation8) |
Mixed ulcers using DC |
2 hours, BID, 5 days a week, for 5 weeks. |
300–500 µA for normally innervated and 500–700 µA for denervated skin 30–110 µA/cm2 |
Treatment n=15, Control n=15. |
Wound healing NS. |
|
Feedar (Citation53) |
Mixed ulcer using pulsed DC |
30 min, BID, 7 days a week, for 4 weeks. |
29.2 V, maximum 29.2 µA, 128 pps. Polarity reversed every 3 days until stage II was reached, then daily reversal with 64 pps |
Treatment n=26 Sham** n=24 |
Wound healing ES 0% vs. sham 4%, p>0.05. |
|
Houghton (Citation63) |
Mixed ulcers using HVPC |
45 min, 3 times a week, for 4 weeks. |
150 V, 100 µs, 100 Hz |
Treatment n=14 Sham** n=13 |
Wound healing NS. |
|
Jankovic (Citation64) |
Mixed ulcers using FREMS |
40 min, daily, 5 days a week, for 3 weeks |
300 V, 1,000 Hz, 10–40 µs, 100–170µA. |
Treatment n=20 |
Wound healing NS. |
|
Lawson (Citation65) |
Mixed wounds using DC |
30 min, three times a week, for 4 weeks. |
5 V, 30 Hz, pulse width 200 µs. Current of 20 mA |
DM I or II: n=8 |
Wound healing NS. |
|
Sarma (Citation55) |
Leprosy ulcers using PEMF |
30 min, daily, 5 days a week, for 35 days. |
Sinusoidal form 0.95–1.05 Hz; amplitude ± 2,400 nT |
Treatment n=18 |
Wound healing ES 6% vs. sham 0%, p>0.05. |
*Single-blind RCT; **double-blind RCT; NS, not stated; pps, pulse per second; NP, neuropathy; RP, retinopathy.
CONCLUSION
The future of electricity in healing wounds holds incredible potential for transforming the landscape of healthcare. Electrical healing techniques, with research ongoing, thoughtful implementation, and a commitment to safety, can transform the face of wound care and present new hope for patients around the globe. As we continue to study this innovative field, the possibilities are so electrifying. Thus, as we conclude, the remarkable possibility of electricity bringing healing to wounds at an accelerated rate opens up a future where innovative medical technologies could revolutionize healthcare practices. Further research and careful implementation promise to enhance patient outcomes, thereby advancing the field of wound care. We stand at the cusp of a new era, where healing is not just faster but more effective and transformative by embracing this electrifying frontier in medicine.
REFERENCES
Vendra Sruthi*, Bonthu Bhavani satya prasad, Electricity Can Renovate Even the Worst Type of Wounds, Int. J. of Pharm. Sci., 2025, Vol 3, Issue 2, 1066-1075. https://doi.org/10.5281/zenodo.14871131
10.5281/zenodo.14871131